# ECG Validation Study

Study · id `cardio:ct-nct05445726` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05445726](<https://clinicaltrials.gov/study/NCT05445726>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05445726

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 141 participants.

## Technical summary

Registry record NCT05445726. Non-randomized; single masking; primary purpose diagnostic. Start 2022-05-19 (actual); primary completion 2022-09-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase: Phase 2
- Enrolled: 141 participants (enrolled count; ClinicalTrials.gov record NCT05445726, source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)
- Started: 2022-05-19 (actual) (ClinicalTrials.gov record NCT05445726, source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)
- Primary completion: 2022-09-02 (actual) (ClinicalTrials.gov record NCT05445726, source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)
- Completion: 2023-11-01 (anticipated) (ClinicalTrials.gov record NCT05445726, source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05445726, source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05445726-2023-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: ECG Validation Study
- Condition: Atrial Fibrillation
- Intervention (Device): CPM Device
- Lead sponsor: Analog Device, Inc.
- Lead sponsor class: OTHER
- Collaborator: Hope Research Institute
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 170640963711dc2f0c111c780c4177a3892274f52f6cc85f8c453ac6eb128c8b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
